| Literature DB >> 23714422 |
Kirstine C Belling, Masami Tanaka, Marlene Danner Dalgaard, John Erik Nielsen, Henrik Bjørn Nielsen, Søren Brunak, Kristian Almstrup, Henrik Leffers.
Abstract
BACKGROUND: Radiotherapy is used routinely to treat testicular cancer. Testicular cells vary in radio-sensitivity and the aim of this study was to investigate cellular and molecular changes caused by low dose irradiation of mice testis and to identify transcripts from different cell types in the adult testis.Entities:
Mesh:
Year: 2013 PMID: 23714422 PMCID: PMC3672050 DOI: 10.1186/1477-7827-11-50
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Testis cell-specific markers mapped to the transcript clusters
| Dazl | Deleted in azoospermia-like | Spermatogonia | 1 |
| 1500011H22Rik | RIKEN cDNA 1500011H22 gene | Spermatocytes | 2 |
| 1700029G01Rik | RIKEN cDNA 1700029G01 gene | Spermatocytes | 3 |
| 2410022L05Rik | RIKEN cDNA 2410022 L05 gene | Spermatocytes | 2 |
| Akap12 | A kinase (PRKA) anchor protein (gravin) 12 | Spermatocytes | 5 |
| Aldoa-ps1 | Aldolase 1, A isoform, retrogene 2 | Spermatocytes | 4 |
| Atl3 | Atlastin GTPase 3 | Spermatocytes | 4 |
| Cypt3 | Cysteine-rich perinuclear theca 3 | Spermatocytes | 3 |
| D030056L22Rik | RIKEN cDNA D030056L22 gene | Spermatocytes | 1 |
| Gsg2 | Germ cell-specific gene 2 | Spermatocytes | 3 |
| H3f3b | H3 histone, family 3B | Spermatocytes | 1 |
| Hnrpa2b1 | Heterogeneous nuclear ribonucleoprotein A2/B1 | Spermatocytes | 1 |
| Lyar | Ly1 antibody reactive clone | Spermatocytes | 2 |
| Nt5c1b | 5′-nucleotidase, cytosolic IB | Spermatocytes | 4 |
| Pgk2 | Phosphoglycerate kinase 2 | Spermatocytes | 4 |
| Slc2a3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Spermatocytes | 2 |
| Spert | Spermatid associated | Spermatocytes | 4 |
| Stard10 | START domain containing 10 | Spermatocytes | 4 |
| Stmn1 | Stathmin 1 | Spermatocytes | 1 |
| Vkorc1 | Vitamin K epoxide reductase complex, subunit 1 | Spermatocytes | 5 |
| Acrv1 | Acrosomal vesicle protein 1 | Spermatids | 3 |
| Actl7a | Actin-like 7a | Spermatids | 4 |
| Akap4 | A kinase (PRKA) anchor protein 4 | Spermatids | 4 |
| Marcksl1 | MARCKS-like 1 | Spermatids | 5 |
| Pdpk1 | 3-phosphoinositide dependent protein kinase-1 | Spermatids | 4 |
| Pdzk1 | PDZ domain containing 1 | Spermatids | 4 |
| Prm1 | Protamine 1 | Spermatids | 2 |
| Spag4l | Sperm associated antigen 4-like | Spermatids | 3 |
| Tctex1d1 | Tctex1 domain containing 1 | Spermatids | 4 |
| Tnp2 | Transition protein 2 | Spermatids | 3 |
| Zpbp | Zona pellucida binding protein | Spermatids | 3 |
| Hsd17b3 | Hydroxysteroid (17-beta) dehydrogenase 3 | Leydig cells | 5 |
| Hsd3b1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Leydig cells | 5 |
| Cyp17a1 | Cytochrome P450, family 17, subfamily a, polypeptide 1 | Leydig cells | 5 |
| Acta2 | Actin, alpha 2, smooth muscle, aorta | PTM cells | 5 |
| Cldn11 | Claudin 11 | Sertoli cells | 5 |
| Clu | Clusterin | Sertoli cells | 5 |
| Ctsl | Cathepsin L | Sertoli cells | 5 |
| Vim | Vimentin | Sertoli cells | 5 |
The table lists the 39 previously published cell-specific markers used to identify the cellular origin of the transcripts clusters [16-18].
Figure 1Gene expression profiles of the five transcript clusters during recovery from irradiation. The clusters contain the subset of 988 transcripts changing in expression during recovery from irradiation, which was separated into clusters by PAM. The number of transcripts in each cluster is stated in the title of each plot. The cell specific markers are coloured as following: Blue: Spermatogonia; Red: Spermatocytes; Green: Spermatids; Purple: Somatic cells.
Figure 2The median z-scaled gene expression of the five transcript clusters during recovery from irradiation. The clusters are coloured as following: Blue: Spermatogonia (cluster 1); Red: Spermatocytes (cluster 2); Green: Early spermatids (cluster 3); Brown: Late spermatids (cluster 4); Purple: Somatic cells (cluster 5).
Significant categories from the GSEA for each transcript clusters performed using DAVID[19,20]
| 1: Spermatogonia | BP | mRNA processing | 11 | 11.83 | 6.12E-07 | 8.22 | 3.11E-04 |
| mRNA metabolic process | 11 | 11.83 | 2.46E-06 | 7.05 | 0.001 | ||
| RNA splicing | 9 | 9.68 | 6.05E-06 | 8,87 | 0.003 | ||
| CC | Ribonucleoprotein complex | 19 | 20.43 | 4.15E-12 | 8.28 | 6.56E-10 | |
| Macromolecular complex | 34 | 36.56 | 5.83E-09 | 2.75 | 9.21E-07 | ||
| Intracellular organelle | 60 | 64.52 | 2.24E-08 | 1.54 | 3.54E-06 | ||
| Organelle | 60 | 64.52 | 2.32E-08 | 1.54 | 3.67E-06 | ||
| Intracellular part | 64 | 68.82 | 4.10E-08 | 1.41 | 6.48E-06 | ||
| Intracellular | 64 | 68.82 | 2.70E-07 | 1.36 | 4.26E-05 | ||
| Intracellular organelle part | 35 | 37.63 | 5.02E-07 | 2.25 | 7.93E-05 | ||
| Organelle part | 35 | 37.63 | 5.95E-07 | 2.24 | 9.40E-05 | ||
| Spliceosome | 8 | 8.60 | 2.23E-06 | 12.97 | 3.53E-04 | ||
| Nucleus | 38 | 40.86 | 1.60E-05 | 1.85 | 0.003 | ||
| Intracellular membrane-bounded organelle | 51 | 54.84 | 4.71E-05 | 1.47 | 0.007 | ||
| Membrane-bounded organelle | 51 | 54.84 | 4.90E-05 | 1.47 | 0.008 | ||
| MF | RNA binding | 21 | 22.58 | 2.81E-12 | 7.11 | 4.35E-10 | |
| Nucleic acid binding | 31 | 33.33 | 1.36E-06 | 2.36 | 2.11E-04 | ||
| 2: Spermatocytes | BP | Sexual reproduction | 18 | 12.41 | 1.02E-09 | 6.70 | 7.80E-07 |
| Gamete generation | 16 | 11.03 | 7.42E-09 | 6.94 | 5.67E-06 | ||
| Male gamete generation | 14 | 9.66 | 2.03E-08 | 7.89 | 1.55E-05 | ||
| Spermatogenesis | 14 | 9.66 | 2.03E-08 | 7.89 | 1.55E-05 | ||
| Multicellular organism reproduction | 16 | 11.03 | 1.22E-07 | 5.62 | 9.34E-05 | ||
| Reproductive process in a multicellular organism | 16 | 11.03 | 1.22E-07 | 5.62 | 9.34E-05 | ||
| Reproductive process | 18 | 12.41 | 1.01E-06 | 4.17 | 7.72E-04 | ||
| Reproduction | 18 | 12.41 | 1.11E-06 | 4.14 | 8.44E-04 | ||
| Cell cycle process | 14 | 9.66 | 2.88E-06 | 5.12 | 0.002 | ||
| CC | Intracellular organelle part | 45 | 31.03 | 1.01E-06 | 2.03 | 2.04E-04 | |
| Macromolecular complex | 39 | 26.90 | 1.16E-06 | 2.21 | 2.36E-04 | ||
| Organelle part | 45 | 31.03 | 1.22E-06 | 2.02 | 2.48E-04 | ||
| Intracellular part | 90 | 62.09 | 1.67E-06 | 1.35 | 3.39E-04 | ||
| Intracellular membrane-bounded organelle | 74 | 51.03 | 6.04E-06 | 1.47 | 0.001 | ||
| Membrane-bounded organelle | 74 | 51.03 | 6.04E-06 | 1.47 | 0.001 | ||
| Intracellular organelle | 80 | 55.17 | 6.71E-06 | 1.41 | 0.001 | ||
| Organelle | 80 | 55.17 | 6.87E-06 | 1.41 | 0.001 | ||
| 3: Early spermatids | BP | Sexual reproduction | 19 | 9.60 | 2.17E-10 | 6.69 | 1.19E-07 |
| Male gamete generation | 13 | 6.57 | 2.33E-07 | 7.03 | 1.28E-04 | ||
| Spermatogenesis | 13 | 6.57 | 2.33E-07 | 7.03 | 1.28E-04 | ||
| Reproductive process | 19 | 9.60 | 3.10E-07 | 4.21 | 1.70E-04 | ||
| Reproduction | 19 | 9.60 | 3.51E-07 | 4.17 | 1.93E-04 | ||
| Gamete generation | 14 | 7.07 | 5.99E-07 | 5.81 | 3.29E-04 | ||
| Multicellular organism reproduction | 14 | 7.07 | 6.43E-06 | 4.69 | 0.004 | ||
| Reproductive process in a multicellular organism | 14 | 7.07 | 6.43E-06 | 4.69 | 0.004 | ||
| CC | Acrosomal vesicle | 10 | 5.05 | 1.06E-10 | 25.52 | 1.76E-08 | |
| Secretory granule | 10 | 5.05 | 1.11E-06 | 9.26 | 1.84E-04 | ||
| 4: Late spermatids | BP | Sexual reproduction | 16 | 7.24 | 4.98E-08 | 6.01 | 2.95E-05 |
| Spermatogenesis | 12 | 5.43 | 1.27E-06 | 6.83 | 7.51E-04 | ||
| Male gamete generation | 12 | 5.43 | 1.27E-06 | 6.83 | 7.51E-04 | ||
| Gamete generation | 13 | 5.88 | 2.51E-06 | 5.70 | 0.001 | ||
| Reproductive process in a multicellular organism | 14 | 6.33 | 3.97E-06 | 4.97 | 0.002 | ||
| Multicellular organism reproduction | 14 | 6.33 | 3.97E-06 | 4.97 | 0.002 | ||
| CC | Cytoplasm | 73 | 33.03 | 1.65E-05 | 1.49 | 0.002 | |
| 5: Somatic cells | BP | Oxidation reduction | 28 | 15.56 | 2.32E-09 | 3.87 | 3.34E-06 |
| Lipid metabolic process | 28 | 15.56 | 4.93E-09 | 3.74 | 7.10E-06 | ||
| Response to oxidative stress | 10 | 5.56 | 3.62E-07 | 10.68 | 5.22E-04 | ||
| Lipid biosynthetic process | 16 | 8.89 | 4.00E-07 | 5.21 | 5.76E-04 | ||
| Cellular ketone metabolic process | 20 | 11.11 | 1.23E-06 | 3.79 | 0.002 | ||
| Oxoacid metabolic process | 19 | 10.56 | 3.61E-06 | 3.69 | 0.005 | ||
| Carboxylic acid metabolic process | 19 | 10.56 | 3.61E-06 | 3.69 | 0.005 | ||
| Organic acid metabolic process | 19 | 10.56 | 3.71E-06 | 3.68 | 0.005 | ||
| Cellular lipid metabolic process | 19 | 10.56 | 3.93E-06 | 3.66 | 0.006 | ||
| Response to hydrogen peroxide | 6 | 3.33 | 4.71E-06 | 23.23 | 0.007 | ||
| CC | Cytoplasm | 114 | 63.33 | 4.81E-13 | 1.68 | 1.11E-10 | |
| Cytoplasmic part | 85 | 47.22 | 1.37E-11 | 1.94 | 3.14E-09 | ||
| Mitochondrion | 37 | 20.56 | 6.64E-08 | 2.67 | 1.53E-05 | ||
| Intracellular part | 128 | 71.11 | 5.25E-06 | 1.27 | 0.001 | ||
| Intracellular | 130 | 72.22 | 2.52E-05 | 1.23 | 0.006 | ||
| MF | Oxidoreductase activity | 29 | 16.11 | 2.67E-10 | 4.12 | 1.02E-07 | |
| Oxidoreductase activity, acting on CH-OH group of donors | 13 | 7.22 | 2.96E-09 | 10.68 | 1.13E-06 | ||
| Oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.67 | 6.67 | 1.19E-08 | 10.91 | 4.56E-06 |
BP: Biological process; CC: Cellular component; MF: Molecular function.
Figure 3IHC staining of the testis tissue pi with Leydig and Sertoli cell markers. Tgfbr3 and Hsd3b were used as Leydig cell markers and Vimentin (Vim) was used as a Sertoli cell marker. Indications of Leydig cell hyperplasia are observed at pi day 21–31, whereas the Sertoli cells do not seem affected. A detailed description of the pictures is found in the text.
Figure 4determination of Leydig cells relative to other testicular cells pi. Areas covered by Leydig cells highly increased following irradiation compared to areas covered by other testicular cells. The peak is observed at pi day 14 where the ratio decreased again.